Cargando…

A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation

PURPOSE: Many treatment modalities exist to counteract the effects of cutaneous aging. Ablative methods have been the mainstay for nonsurgical facial rejuvenation. In recent years, nonablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage. Ligh...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolis, Andreas, Bernstein, Steven, Kinney, Brian, Scuderi, Nicolo, Rastogi, Shipra, Sampalis, John S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874553/
https://www.ncbi.nlm.nih.gov/pubmed/27257391
http://dx.doi.org/10.2147/CCID.S100697
_version_ 1782433054853169152
author Nikolis, Andreas
Bernstein, Steven
Kinney, Brian
Scuderi, Nicolo
Rastogi, Shipra
Sampalis, John S
author_facet Nikolis, Andreas
Bernstein, Steven
Kinney, Brian
Scuderi, Nicolo
Rastogi, Shipra
Sampalis, John S
author_sort Nikolis, Andreas
collection PubMed
description PURPOSE: Many treatment modalities exist to counteract the effects of cutaneous aging. Ablative methods have been the mainstay for nonsurgical facial rejuvenation. In recent years, nonablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage. Light-emitting diode (LED) photorejuvenation is a novel nonablative technique that induces collagen synthesis through biophotomodulatory pathways. MATERIALS AND METHODS: A single-center, randomized, single-blinded, placebo-controlled, split-faced clinical trial was designed. Thirty-two patients were enrolled for a 12-week study. Patients were randomized into one of four groups: Group A, treatment with KLOX-001 gel formulation and white LED (placebo) light; Group B, treatment with a placebo/base gel (no active chromophore) formulation and KLOX LED light; Group C, treatment with KLOX-001 gel formulation and KLOX LED light; and Group D, treatment with the standard skin rejuvenating treatment (0.1% retinol-based cream). Patients received treatment at weeks 0, 1, 2, and 3, and returned to the clinic at weeks 4, 8, and 12 for clinical assessments performed by an independent, blinded committee of physicians using subjective clinician assessment scales. Tolerability, adverse outcomes, and patient satisfaction were also assessed. RESULTS: Analysis demonstrated that the KLOX LED light with KLOX placebo/base gel and the KLOX LED light + KLOX-001 gel formulation groups were superior to standard of care and KLOX-001 gel formulation with placebo light on subjective clinical assessment and multiple wrinkle scales, with statistically significant results obtained for brow positioning, perioral wrinkling, and total wrinkle score. CONCLUSION: The study results show that KLOX LED light with KLOX-001 gel formulation and KLOX LED light with KLOX placebo/base gel are effective, safe, well-tolerated, and painless treatment modalities for skin rejuvenation.
format Online
Article
Text
id pubmed-4874553
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48745532016-06-02 A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation Nikolis, Andreas Bernstein, Steven Kinney, Brian Scuderi, Nicolo Rastogi, Shipra Sampalis, John S Clin Cosmet Investig Dermatol Clinical Trial Report PURPOSE: Many treatment modalities exist to counteract the effects of cutaneous aging. Ablative methods have been the mainstay for nonsurgical facial rejuvenation. In recent years, nonablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage. Light-emitting diode (LED) photorejuvenation is a novel nonablative technique that induces collagen synthesis through biophotomodulatory pathways. MATERIALS AND METHODS: A single-center, randomized, single-blinded, placebo-controlled, split-faced clinical trial was designed. Thirty-two patients were enrolled for a 12-week study. Patients were randomized into one of four groups: Group A, treatment with KLOX-001 gel formulation and white LED (placebo) light; Group B, treatment with a placebo/base gel (no active chromophore) formulation and KLOX LED light; Group C, treatment with KLOX-001 gel formulation and KLOX LED light; and Group D, treatment with the standard skin rejuvenating treatment (0.1% retinol-based cream). Patients received treatment at weeks 0, 1, 2, and 3, and returned to the clinic at weeks 4, 8, and 12 for clinical assessments performed by an independent, blinded committee of physicians using subjective clinician assessment scales. Tolerability, adverse outcomes, and patient satisfaction were also assessed. RESULTS: Analysis demonstrated that the KLOX LED light with KLOX placebo/base gel and the KLOX LED light + KLOX-001 gel formulation groups were superior to standard of care and KLOX-001 gel formulation with placebo light on subjective clinical assessment and multiple wrinkle scales, with statistically significant results obtained for brow positioning, perioral wrinkling, and total wrinkle score. CONCLUSION: The study results show that KLOX LED light with KLOX-001 gel formulation and KLOX LED light with KLOX placebo/base gel are effective, safe, well-tolerated, and painless treatment modalities for skin rejuvenation. Dove Medical Press 2016-05-13 /pmc/articles/PMC4874553/ /pubmed/27257391 http://dx.doi.org/10.2147/CCID.S100697 Text en © 2016 Nikolis et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Clinical Trial Report
Nikolis, Andreas
Bernstein, Steven
Kinney, Brian
Scuderi, Nicolo
Rastogi, Shipra
Sampalis, John S
A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation
title A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation
title_full A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation
title_fullStr A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation
title_full_unstemmed A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation
title_short A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation
title_sort randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of klox-001 gel formulation with klox light-emitting diode light on facial rejuvenation
topic Clinical Trial Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874553/
https://www.ncbi.nlm.nih.gov/pubmed/27257391
http://dx.doi.org/10.2147/CCID.S100697
work_keys_str_mv AT nikolisandreas arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT bernsteinsteven arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT kinneybrian arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT scuderinicolo arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT rastogishipra arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT sampalisjohns arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT nikolisandreas randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT bernsteinsteven randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT kinneybrian randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT scuderinicolo randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT rastogishipra randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation
AT sampalisjohns randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation